Referring Physicians

This page is under construction. We are updating this section to incorporate new developments like N-13 Ammonia for Cardiac and F-18 Fluoroestradiol in Estrogen Receptor-Positive Breast Cancer which will be available in early 2021. We're watching the progress of Biogen's application to the FDA (which was accepted for priority review on 8/7/2020) for its Alzheimer’s Disease therapeutic drug, Aducanumab.